What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Big buy
Patrick J Heron: large open-market buy of MBX
$12M open-market purchase by Patrick J Heron, Director at Mbx Biosciences,Inc., filed September 30, 2025. Learn more
Feed status Last SEC check:Loading Last Filing: Loading
View MBX
Access Free feed
Quick read What does this view show?
Why it matters
Read the SEC filing
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Role, size, timing
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Key insider views at a glance
Big BuyMBX
$40.09+2.85% today
Patrick J Heron · Director at Mbx Biosciences,Inc.
$12M
Patrick J Heron bought $12M of MBX (Mbx Biosciences,Inc.).
Insider purchase
Transaction details
Patrick J Heron, a Director, reported a $12M open-market purchase equal to 0.83% of MBX's market cap.
Patrick J Heron (Director) bought 666,666 shares of MBX, Mbx Biosciences,Inc., Healthcare ($1.44B market cap), at $18.00 per share on September 26, 2025 for a total of $12M (0.83% of the market cap).
Patrick J Heron
Director
Purchase value$12M
Shares purchased666,666
Price per share$18.00 per share
- % of market cap
- 0.83%
- Trade date
- September 26, 2025
- Filed
- September 30, 2025
- Filing delay
- 4 days
Permalink https://bluecollarpicks.com/insider-trading/MBX/buy/67947
Market context
MBX market snapshot
Current price$40.09
1-day change+2.85%
Market cap$1.44B
SectorHealthcare
Next earningsAugust 5, 2026
$40.09
Current price$40.09
Analyst target$69.09 (+128.2%)
Last enriched June 17, 2026 at 9:01 AM EDT.
Filings
Recent insider trades
Status Loading
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant Director | Not reported | ||
Grant Director | $0 | ||
Big Buy CEO | $525.7K | ||
Exercise and Hold CEO | $460.3K | ||
Exercise and Hold CEO | Not reported | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Grant CFO | $0 | ||
Grant CFO | $0 | ||
Grant CEO | $0 | ||
Grant CEO | $0 | ||
Grant Director | $0 | ||
Cluster Buy CEO | $272.8K | ||
Cluster Buy Director | $265K | ||
| This filing | Big Buy Director | $12M | |
Buy Director | $45.3K | ||
Cluster Buy Director | $1M | ||
Cluster Buy Director | $531.9K | ||
Cluster Buy Director | $531.9K | ||
Cluster Buy Director | $1M | ||
Cluster Buy Director | $1M | ||
Cluster Buy Director | $1M | ||
Cluster Buy Director | $531.9K | ||
Cluster Buy Director | $531.9K | ||
Cluster Buy Director | $291K | ||
Cluster Buy Director | $177.8K | ||
Cluster Buy Director | $291K | ||
Cluster Buy Director | $291K | ||
Cluster Buy Director | $291K | ||
Cluster Buy Director | $177.8K | ||
Cluster Buy Director | $177.8K | ||
Cluster Buy Director | $177.8K | ||
Big Buy CEO | $534.5K | ||
Grant Director
Grant Director
Grant Director
Not reported
Grant Director
Grant Director
$525.7K
Big Buy CEO
$460.3K
Exercise and Hold CEO
Not reported
Exercise and Hold CEO
Grant Officer
Grant Officer
Grant CFO
Grant CFO
Grant CEO
Grant CEO
Grant Director
$272.8K
Cluster Buy CEO
$265K
Cluster Buy Director
$12M
Big Buy Director
$45.3K
Buy Director
$1M
Cluster Buy Director
$531.9K
Cluster Buy Director
$531.9K
Cluster Buy Director
Cluster Buy Director
Cluster Buy Director
Cluster Buy Director
$531.9K
Cluster Buy Director
$531.9K
Cluster Buy Director
$291K
Cluster Buy Director
$177.8K
Cluster Buy Director
Cluster Buy Director
$291K
Cluster Buy Director
$291K
Cluster Buy Director
$177.8K
Cluster Buy Director
$177.8K
Cluster Buy Director
$177.8K
Cluster Buy Director
$534.5K
Big Buy CEO
Cluster detail
Cluster members
Ticker context
Ticker summary
Recent insider activity for this company.
Insider detail
Insider activity
Recent transactions grouped by reporting owner.
Filters
Filters
Weekly recap
Get the easier version in your inbox.
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
CSV exports are becoming a paid feature.
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.